FTC to debate deal on generic form of Prozac

Article Abstract:

FTC members are expected to approve a staff recommendation which would oppose a deal proposed by Eli Lilly which would prevent generic competition from its antidepressant drug Prozac for another 10 years. The deal calls for Eli Lilly to pay $90 million to Sepracor to license a purified version of Eli Lilly's Prozac. While a number of Prozac's patents are set to expire soon, newer formulations and versions could extend the drug's patent to 2004. The deal with Sepracor could enable Eli Lilly to extend Prozac's patent until 2014.

Antidepressant Preparations, Antidepressants

---

Credit card firms face Justice suit

Article Abstract:

Visa USA and MasterCard International will face antitrust lawsuits regarding their policies of not allowing banks that offer their cards from offering other credit cards, such as American Express. The action is a result of an investigation conducted by Justice officials in 1996 in response to the complaint of American Express who said such policy had been reversed in all other countries in which it does business, except in Canada, where it is currently under review. Kelly Presta of Visa said that the company stands by the policy for the consumers' interest and that there is already a strong competition between Visa and MasterCard.

Comment:

Faces antitrust lawsuit filed by the Justice Dept for not allowing banks that offer their cards from offering other credit cards

Commercial Banking, Bank Credit Cards, MasterCard International Inc., Visa U.S.A. Inc., Article

---

Cancer drug probe picks up

Article Abstract:

Zeneca Ltd, which produces the breast cancer drug tamoxifen, has been facing a formal probe by the Justice Department concerning a 1993 transaction between the company and BARR Laboratories Inc. Zeneca filed a patent-violation suit when Barr filed to market generic tamoxifen. However, the two firms reached a settlement that called for Zeneca to pay Barr $21 million and a US distribution rights is given to the latter for the generic version of tamoxifen.

Anticancer Drugs, Antineoplastic agents, Barr Laboratories Inc., Zeneca Ltd.

Similar abstracts:

• Abstracts: FTC nears deal on AOL-Time Warner merger. Competing ISP key to merger. Merger can expect tough regulatory look
• Abstracts: The inkjet color image, born in a rainbow of tiny drops. Lifting the cover of those ubiquitous touch screens. Photos go beyond the inkjet
• Abstracts: Pushing the envelope for creative violence. Oh, yes! The lemmings are back! Oh, no! Dull adventure? Send in the secret agent
• Abstracts: More fliers land on the Internet to air complaints. Airline deals go full throttle. Delta seeks panel to delay pilots strike

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.